DiaMedica Therapeutics In... (DMAC)
undefined
undefined%
At close: undefined
5.38
-0.92%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income -19.38M -13.68M -13.59M -12.29M -10.65M -5.73M -4.26M -2.22M -1.44M -4.82M -7.41M -10.05M -6.61M -4.27M -2.44M -1.85M -2.33M -778.02K -210.60K -640.02K
Depreciation & Amortization 30.00K 25.00K 24.00K 21.00K 21.00K 15.00K 4.00K 2.20K 4.11K 2.47K 1.11M 2.37M 2.30M 1.67M 30.20K 26.74K 18.35K 3.32K 28.15K 6.41K
Stock-Based Compensation 1.68M 1.50M 1.56M 1.84M 1.16M 620.00K 409.00K 263.31K 125.49K 343.30K 704.57K 1.03M - 294.49K 252.40K 155.33K - - - -
Other Working Capital -99.00K 360.00K 129.00K 278.00K 731.00K 64.00K 491.00K -244.72K -52.97K 433.23K 66.58K 1.17M 36.23K 21.95K -23.88K -4.94K 142.90K -26.46K -655.16K 500.30K
Other Non-Cash Items -1.15M 53.00K 58.00K 52.00K 49.00K 39.00K -93.60K 22.86K -21.54K 621.61K 734.35K 1.03M 832.58K 294.49K 294.09K 318.76K 958.90K 0.00 6.44K 33.95K
Deferred Income Tax - - 161.00K -4.00K -74.00K - 84.60K -169.95K 21.54K -343.30K -704.57K -1.03M - -218.26K -252.40K -155.33K - - - -
Change in Working Capital 93.00K 585.00K -461.00K 1.20M 387.00K -636.00K -44.00K -918.45K -52.97K 437.98K 66.58K 1.17M 36.23K -148.89K -35.59K 41.67K 142.90K -26.46K -655.16K 500.30K
Operating Cash Flow -18.73M -11.51M -12.25M -9.19M -9.10M -5.70M -3.90M -3.02M -1.37M -3.76M -5.50M -5.48M -3.44M -2.38M -2.15M -1.47M -1.21M -801.16K -831.17K -99.35K
Capital Expenditures -24.00K -81.00K -22.00K -47.00K -2.00K -50.00K -22.00K -6.89K -5.39K -31.33K -134.27K -63.37K -79.31K -57.76K -92.09K -85.26K -296.17K -108.89K -76.99K -103.46K
Acquisitions - -11.62K 2.00K 16.00K 13.00K - - 1.50K - - - - - 148.98 - - - - - -
Purchase of Investments -69.41M -45.68M -69.81M -39.75M -12.92M - - - - - - - - - - - - - - -
Sales Maturities Of Investments 51.13M 57.30M 49.30M 23.64M 9.00M - - - - - - - - - - - - - - -
Other Investing Acitivies - 11.62K -20.52K -16.09K -3.91K - - 1.50 - -31.4 -116.59 -59.48 - - - - - - - -
Investing Cash Flow -18.30M 11.54M -20.54M -16.13M -3.91M -50.00K -22.00K -6.89K -5.39K -31.33K -134.27K -63.37K -79.31K -57.61K -92.09K -85.26K -296.17K -108.89K -76.99K -103.46K
Debt Repayment -6.00K -6.00K -6.00K -5.00K -5.00K - - - - - - - - - - - - - -174.08K 134.91K
Common Stock Repurchased - - - - - - - - - - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies - 0.00 244.00K 45.00K 75.00K 650.00K 622.00K 470.63K -22.56K 152.49K 95.44K 5.16M 211.56K 2.82M - - - - -0.3 0.00
Financial Cash Flow 36.84M -6.00K 30.09K 28.84M 70.00K 21.22M 3.54M 4.59M 1.37M 1.68M 5.97M 5.17M 3.39M 4.61M - 1.17M 4.69M 905.88K 1.18M 159.51K
Net Cash Flow -185.00K 21.00K -2.70M 3.53M -12.94M 15.47M -383.00K 1.57M -4.78K -2.11M 335.14K -381.99K -126.90K 2.18M -2.24M -381.43K 3.18M -4.17K 266.86K -43.31K
Free Cash Flow -18.75M -11.59M -12.27M -9.23M -9.10M -5.75M -3.92M -3.03M -1.37M -3.79M -5.64M -5.55M -3.52M -2.43M -2.24M -1.55M -1.51M -910.05K -908.15K -202.82K